Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

BACKGROUND: Antimicrobial resistance in Pseudomonas aeruginosa is complex and multifaceted. While the novel β-lactamase inhibitors (BLIs) avibactam, relebactam and vaborbactam inhibit serine-based β-lactamases, the comparative potency of the novel β-lactam (BL)/BLI combinations against serine carbap...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Young, Gill, Christian M, Nicolau, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689909/
https://www.ncbi.nlm.nih.gov/pubmed/37840005
http://dx.doi.org/10.1093/jac/dkad225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689909/
https://www.ncbi.nlm.nih.gov/pubmed/37840005
http://dx.doi.org/10.1093/jac/dkad225

Ejemplares similares